0001209191-23-057915.txt : 20231208
0001209191-23-057915.hdr.sgml : 20231208
20231208162608
ACCESSION NUMBER: 0001209191-23-057915
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231206
FILED AS OF DATE: 20231208
DATE AS OF CHANGE: 20231208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Epperly Corinne
CENTRAL INDEX KEY: 0001839156
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39692
FILM NUMBER: 231475740
MAIL ADDRESS:
STREET 1: AVEO PHARMACEUTICALS, INC.
STREET 2: 30 WINTER STREET
CITY: BOSTON
STATE: MA
ZIP: 02108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IN8BIO, INC.
CENTRAL INDEX KEY: 0001740279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 825462585
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: EMPIRE STATE BUILDING
STREET 2: 350 5TH AVENUE, SUITE 5330
CITY: NEW YORK
STATE: NY
ZIP: 10118
BUSINESS PHONE: (646) 600-6438
MAIL ADDRESS:
STREET 1: EMPIRE STATE BUILDING
STREET 2: 350 5TH AVENUE, SUITE 5330
CITY: NEW YORK
STATE: NY
ZIP: 10118
FORMER COMPANY:
FORMER CONFORMED NAME: Incysus Therapeutics, Inc.
DATE OF NAME CHANGE: 20180510
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-06
0
0001740279
IN8BIO, INC.
INAB
0001839156
Epperly Corinne
C/O IN8BIO, INC.
350 5TH AVENUE, SUITE 5330
NEW YORK
NY
10118
1
0
0
0
0
Stock Option (right to buy)
1.04
2023-12-06
4
A
0
54800
0.00
A
2033-12-06
Common Stock
54800
54800
D
One thirty-sixth (1/36th) of the shares subject to the option shall vest in equal monthly installments commencing on January 6, 2024, subject to the Reporting Person continuing to provide service through each such date.
/s/ Jason Minio, Attorney-in-Fact
2023-12-08